Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Julien Potet "Why miltefosine -a life-saving drug for #leishmaniasis- is unavailable to people who need it the most": our case study found that drug access for #NTDs is some sort of a permanent challenge; vigilance is warranted @SunyotoTemmy @Euroleish_net 00:28 - 04 May 2018